vs

Side-by-side financial comparison of Creative Media & Community Trust Corp (CMCT) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.

IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $28.5M, roughly 1.7× Creative Media & Community Trust Corp). IRONWOOD PHARMACEUTICALS INC runs the higher net margin — -4.8% vs -125.8%, a 121.0% gap on every dollar of revenue. On growth, Creative Media & Community Trust Corp posted the faster year-over-year revenue change (3.6% vs -47.3%). Over the past eight quarters, Creative Media & Community Trust Corp's revenue compounded faster (-8.5% CAGR vs -20.2%).

Creative Media & Community Trust Corp is a U.S.-headquartered real estate investment trust operating two core segments: it owns, manages and develops creative media facilities including professional film and TV production studios, plus community-focused assets such as affordable housing, neighborhood healthcare centers and local commercial spaces, serving media operators and local communities nationwide.

Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.

CMCT vs IRWD — Head-to-Head

Bigger by revenue
IRWD
IRWD
1.7× larger
IRWD
$47.7M
$28.5M
CMCT
Growing faster (revenue YoY)
CMCT
CMCT
+50.9% gap
CMCT
3.6%
-47.3%
IRWD
Higher net margin
IRWD
IRWD
121.0% more per $
IRWD
-4.8%
-125.8%
CMCT
Faster 2-yr revenue CAGR
CMCT
CMCT
Annualised
CMCT
-8.5%
-20.2%
IRWD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CMCT
CMCT
IRWD
IRWD
Revenue
$28.5M
$47.7M
Net Profit
$-11.4M
$-2.3M
Gross Margin
Operating Margin
-125.6%
14.3%
Net Margin
-125.8%
-4.8%
Revenue YoY
3.6%
-47.3%
Net Profit YoY
-11.4%
-200.9%
EPS (diluted)
$-3.89
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMCT
CMCT
IRWD
IRWD
Q4 25
$28.5M
$47.7M
Q3 25
$26.2M
$122.1M
Q2 25
$29.7M
$85.2M
Q1 25
$32.3M
$41.1M
Q4 24
$27.5M
$90.5M
Q3 24
$28.6M
$91.6M
Q2 24
$34.4M
$94.4M
Q1 24
$34.0M
$74.9M
Net Profit
CMCT
CMCT
IRWD
IRWD
Q4 25
$-11.4M
$-2.3M
Q3 25
$-12.5M
$40.1M
Q2 25
$-9.0M
$23.6M
Q1 25
$-6.1M
$-37.4M
Q4 24
$-10.3M
$2.3M
Q3 24
$-10.4M
$3.6M
Q2 24
$-796.0K
$-860.0K
Q1 24
$-3.7M
$-4.2M
Operating Margin
CMCT
CMCT
IRWD
IRWD
Q4 25
-125.6%
14.3%
Q3 25
-47.7%
61.8%
Q2 25
-30.3%
53.2%
Q1 25
-19.0%
-70.7%
Q4 24
-128.8%
34.8%
Q3 24
-36.9%
28.0%
Q2 24
-1.6%
26.5%
Q1 24
-10.7%
14.7%
Net Margin
CMCT
CMCT
IRWD
IRWD
Q4 25
-125.8%
-4.8%
Q3 25
-47.5%
32.8%
Q2 25
-30.3%
27.7%
Q1 25
-18.9%
-90.9%
Q4 24
-129.8%
2.5%
Q3 24
-36.3%
4.0%
Q2 24
-2.3%
-0.9%
Q1 24
-11.0%
-5.6%
EPS (diluted)
CMCT
CMCT
IRWD
IRWD
Q4 25
$-3.89
$0.01
Q3 25
$-23.52
$0.23
Q2 25
$-18.94
$0.14
Q1 25
$-20.73
$-0.23
Q4 24
$97.71
$0.03
Q3 24
$-305.04
$0.02
Q2 24
$-98.64
$-0.01
Q1 24
$-125.46
$-0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMCT
CMCT
IRWD
IRWD
Cash + ST InvestmentsLiquidity on hand
$15.4M
$215.5M
Total DebtLower is stronger
$509.8M
Stockholders' EquityBook value
$265.4M
$-261.8M
Total Assets
$859.2M
$396.9M
Debt / EquityLower = less leverage
1.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMCT
CMCT
IRWD
IRWD
Q4 25
$15.4M
$215.5M
Q3 25
$17.3M
$140.4M
Q2 25
$27.8M
$92.9M
Q1 25
$19.8M
$108.5M
Q4 24
$20.3M
$88.6M
Q3 24
$18.5M
$88.2M
Q2 24
$29.3M
$105.5M
Q1 24
$21.3M
$121.5M
Total Debt
CMCT
CMCT
IRWD
IRWD
Q4 25
$509.8M
Q3 25
$527.8M
$199.5M
Q2 25
$535.6M
$199.3M
Q1 25
$512.7M
$199.2M
Q4 24
$505.7M
$199.0M
Q3 24
$478.3M
$198.8M
Q2 24
$485.1M
$198.6M
Q1 24
$472.8M
$398.3M
Stockholders' Equity
CMCT
CMCT
IRWD
IRWD
Q4 25
$265.4M
$-261.8M
Q3 25
$281.9M
$-264.2M
Q2 25
$287.1M
$-308.2M
Q1 25
$293.0M
$-334.1M
Q4 24
$304.5M
$-301.3M
Q3 24
$321.0M
$-311.3M
Q2 24
$351.1M
$-321.7M
Q1 24
$369.9M
$-330.5M
Total Assets
CMCT
CMCT
IRWD
IRWD
Q4 25
$859.2M
$396.9M
Q3 25
$871.8M
$396.1M
Q2 25
$885.0M
$342.9M
Q1 25
$882.3M
$327.2M
Q4 24
$889.6M
$350.9M
Q3 24
$868.0M
$389.5M
Q2 24
$891.2M
$395.6M
Q1 24
$887.5M
$438.8M
Debt / Equity
CMCT
CMCT
IRWD
IRWD
Q4 25
1.92×
Q3 25
1.87×
Q2 25
1.87×
Q1 25
1.75×
Q4 24
1.66×
Q3 24
1.49×
Q2 24
1.38×
Q1 24
1.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMCT
CMCT
IRWD
IRWD
Operating Cash FlowLast quarter
$5.8M
$74.6M
Free Cash FlowOCF − Capex
$74.6M
FCF MarginFCF / Revenue
156.3%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$127.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMCT
CMCT
IRWD
IRWD
Q4 25
$5.8M
$74.6M
Q3 25
$3.7M
$47.6M
Q2 25
$-2.5M
$-15.1M
Q1 25
$1.2M
$20.0M
Q4 24
$17.0M
$15.2M
Q3 24
$10.3M
$9.9M
Q2 24
$3.9M
$33.5M
Q1 24
$1.6M
$45.0M
Free Cash Flow
CMCT
CMCT
IRWD
IRWD
Q4 25
$74.6M
Q3 25
$47.6M
Q2 25
$-15.1M
Q1 25
$19.9M
Q4 24
Q3 24
$9.9M
Q2 24
$33.4M
Q1 24
$44.9M
FCF Margin
CMCT
CMCT
IRWD
IRWD
Q4 25
156.3%
Q3 25
39.0%
Q2 25
-17.7%
Q1 25
48.4%
Q4 24
Q3 24
10.8%
Q2 24
35.4%
Q1 24
60.0%
Capex Intensity
CMCT
CMCT
IRWD
IRWD
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.1%
Q4 24
0.0%
Q3 24
0.0%
Q2 24
0.1%
Q1 24
0.1%
Cash Conversion
CMCT
CMCT
IRWD
IRWD
Q4 25
Q3 25
1.19×
Q2 25
-0.64×
Q1 25
Q4 24
6.74×
Q3 24
2.71×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons